Your browser doesn't support javascript.
loading
Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
Wu, Hui-Chen; Jeng, Wen-Juei; Pan, Mei-Hung; Hsieh, Yi-Chung; Lu, Sheng-Nan; Chen, Chien-Jen; Yang, Hwai-I.
Afiliação
  • Wu HC; Department of Environmental Health Sciences, Mailman School of Public Health of Columbia University, New York, NY, USA.
  • Jeng WJ; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
  • Pan MH; Division of Hepatogastroenterology, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.
  • Hsieh YC; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
  • Lu SN; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Chen CJ; Division of Hepatogastroenterology, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.
  • Yang HI; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
JHEP Rep ; 4(2): 100410, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35079699
ABSTRACT
BACKGROUND &

AIMS:

In addition to HBV/HCV causing hepatocellular carcinoma (HCC), other risk factors including obesity and alcohol drinking also increase risk. We describe the cumulative risk of HCC and mortality from liver-related disease by selected modifiable risk factors among a non-hepatitis virus-infected population.

METHODS:

For a community-based cohort, residents aged 30-65 years living in 7 townships in Taiwan were recruited, and have been followed up since 1991. A total of 18,541 individuals were seronegative for markers of chronic infection of HBV/HCV and with no history of HCC at baseline. New non-HBV/HCV HCC cases and liver-related deaths were ascertained through data linkage to the National Cancer Registry and Death Certification System from 1 January 1991 through 31 December 2017.

RESULTS:

There were 207 HCC cases and 215 liver-related deaths identified. The incidence rate of non-HBV/HCV HCC was 47.2 per 100,000 person-years. The mortality rate of liver-related death was 49.0 per 100,000 person-years. Baseline information on alcohol consumption, heart disease, diabetes, elevated aspartate aminotransferase, and alanine aminotransferase predicted higher risks of HCC, with hazard ratios (HRs) (95% CIs) of 1.7 (1.1-2.5), 2.2 (1.1-4.1), 1.9 (1.0-3.5), 1.7 (1.1-2.4), and 1.6 (1.0-2.4), respectively. The HRs (95% CIs) of liver-related death were 2.3 (1.6-3.2) for alcohol consumption, 1.4 (1.1-1.9) for BMI ≥25 kg/m2, 2.2 (1.4-3.3) for elevated aspartate aminotransferase, and 1.5 (1.0-2.4) for elevated alanine aminotransferase. The HR (95% CI) was 8.1 (3.6-18.5) for those with diabetes and elevated aspartate aminotransferase.

CONCLUSIONS:

Individuals with elevated liver enzymes are at high risk of liver disease. Prevention and treatment of diabetes and heart disease are critical for non-hepatitis B, non-hepatitis C (NonB/C)-HCC. LAY

SUMMARY:

We followed up individuals with no chronic HBV or HCV infection and described the risk of hepatocellular carcinoma (HCC, the most common form of primary liver cancer) and mortality from liver-related disease by modifiable risk factors. This study estimated the incidence rate of HCC by selected lifestyle risk factors and chronic diseases conditions. Alcohol consumption, heart disease, diabetes, and abnormal blood liver function tests showed a strong association with HCC risk and mortality.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article